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Structure of Escherichia coli ribokinase in complex with ribose
and dinucleotide determined to 1.8 Å resolution: insights into a
new family of kinase structures
Jill A Sigrell1, Alexander D Cameron1, T Alwyn Jones1 and Sherry L Mowbray2*
Background:  D-ribose must be phosphorylated at O5′ before it can be used in
either anabolism or catabolism. This reaction is catalysed by ribokinase and
requires the presence of ATP and magnesium. Ribokinase is a member of a
family of carbohydrate kinases of previously unknown structure.
Results:  The crystal structure of ribokinase from Escherichia coli in complex
with ribose and dinucleotide was determined at 1.84 Å resolution by multiple
isomorphous replacement. There is one 33 kDa monomer of ribokinase in the
asymmetric unit, but the protein forms a dimer around a crystallographic twofold
axis. Each subunit consists of a central α/β unit, with a new type of nucleotide-
binding fold, and a distinct β sheet that forms a lid over the ribose-binding site.
Contact between subunits involves orthogonal packing of β sheets, in a novel
dimer interaction that we call a β clasp. 
Conclusions:  Inspection of the complex indicates that ribokinase utilises both
a catalytic base for activation of the ribose in nucleophilic attack and an anion
hole that stabilises the transition state during phosphoryl transfer. The structure
suggests an ordered reaction mechanism, similar to those proposed for other
carbohydrate kinases, that probably involves conformational changes. We
propose that the β-clasp structure acts as a lid, closing and opening upon
binding and release of ribose. From these observations, an understanding of the
structure and catalytic mechanism of related sugar kinases can be obtained.
Introduction
D-ribose is an abundant sugar that is an energy source as
well as a component of RNA, DNA and many cofactors.
As such, it is one of the few compounds that Escherichia
coli can sense and actively seek out through chemotaxis.
During uptake, ribose diffuses through the outer cell
membrane into the periplasm, where it becomes bound by
the ribose-binding protein. The ribose-binding protein
can then interact either with the membrane-bound
chemotaxis receptor or with the permease that transports
ribose across the inner membrane [1].
When D-ribose enters the cytoplasm of the cell, it must be
phosphorylated before it can be used. This essential phos-
phorylation reaction is catalysed by ribokinase (EC
2.7.1.15) and requires the presence of ATP and
magnesium. The product, D-ribose-5-phosphate, is then
available for the synthesis of nucleotides, tryptophan and
histidine, or for entry into the pentose phosphate pathway.
This enzyme is also important for recycling sugar pro-
duced by nucleotide breakdown.
The gene coding for E. coli ribokinase is located on the
same operon as those for the periplasmic ribose-binding
protein and the membrane-bound permease system [2,3].
Ribokinase, like the other proteins encoded by genes of
this operon, is normally expressed at a low level, but it is
induced in the presence of ribose [4]. Metabolic enzymes
are not usually found together with their transport compo-
nents and this situation probably reflects the essential role
of ribokinase in ribose metabolism [4].
Ribokinase genes have been cloned from both prokaryotes
and eukaryotes, and sequence comparisons have shown that
they belong to a single family [5,6]. This ribokinase family,
also called the PfkB family of carbohydrate kinases,
includes ribokinase, ketohexokinase, adenosinekinase,
fructokinase, 2-dehydro-3-deoxygluconokinase, 1-phospho-
fructokinase and the minor 6-phosphofructokinase (PfkB).
In this paper, we describe the structure of E. coli
ribokinase in complex with D-ribose and a nucleotide
analogue at 1.84 Å resolution. This is the first three-
dimensional structure to be solved in this family of pro-
teins. Although the supposedly non-hydrolysable ATP
analogue AMP–PNP was included in the crystallisation
mixture, only a dinucleotide was observed to be bound in
the active site.
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Results and discussion
The three-dimensional crystal structure of E.coli riboki-
nase was determined by the multiple isomorphous
replacement method using mercury acetate and a
selenomethionine (SeMet) substituted form of the
enzyme as heavy-atom derivatives. The structure was
refined at 1.84 Å resolution to a crystallographic R factor of
22.0% and an Rfree [7] of 25.8%. There is one monomer of
ribokinase in the asymmetric unit, but a dimer is formed
around a crystallographic twofold axis. The molecular
model has good stereochemistry and includes 306 out of
309 protein residues, ribose, dinucleotide, two inorganic
phosphates and 181 water molecules.
Overall structure and fold of the subunit
The ribokinase subunit can be divided into two parts: a
central α/β fold and a distinct β sheet that protrudes from
it (Figure 1). The α/β fold consists of a twisted nine-
stranded β sheet flanked on both faces by α helices. The
first six strands of the β sheet are parallel and, together
with the associated α helices, have the topology of a classi-
cal NAD-binding domain (Rossmann fold; [8]). The
ribokinase fold is extended, however, by three additional
β strands (β11–β13) that are connected by short reverse
turns. Both faces of this extension are also shielded by
helices — on one side a pair that link to the first part of
the fold and on the other by two of the three C-terminal
helices. A 12-residue loop connects the edge strand (β13)
to α8; this helix packs parallel to α1 near the middle of the
β sheet.
The protruding β sheet is formed by two insertions into
the central α/β fold. The first insertion is located in the
loop connecting β1 and α1, and the second is in the cross-
over point linking β5 and α3; each insertion contributes
two antiparallel β strands. The resulting sheet is posi-
tioned near the C-terminal edge of the larger sheet of the
α/β fold, thus capping the site normally associated with
nucleotide binding (Figure 1). The longest strand (β3)
contains a central β bend [9] at residues 33–35, which
causes it to curve through approximately 90°. We will refer
to the two parts of this strand as β3a and β3b.
Various systematic searches among previously determined
structures [10,11] failed to detect significant relationships
to the intact protein or the complete α/β unit, although
many similarities were detected between the Rossmann
fold-containing portion of ribokinase and NAD-binding
proteins (see discussion of active site).
The dimer interaction
Light scattering and gel filtration studies have demon-
strated that E. coli ribokinase is primarily a dimer in solu-
tion [12]. In the crystal structure, the dimer is formed
around a crystallographic twofold axis with a single
monomer in the asymmetric unit. The dimer interface
results from the interaction of the β sheets that protrude
from each subunit. These β sheets pack almost orthogo-
nally to each other, forming a flattened barrel (Figure 2).
The β bend in the middle of β3 allows this strand to par-
ticipate in both sheets of the dimer contact region, with
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Figure 1
Schematic representations of a ribokinase subunit, colour ramped
according to residue number starting with red at the N terminus and
finishing with blue at the C terminus. (a) Ribbon diagram showing
substrates ribose, ADP and phosphate in ball-and-stick
representations; strands are labelled (β1–β13). The figure was
prepared using MOLSCRIPT [49] as modified by R Esnouf [50]. (b)
Topology diagram prepared using SHOWCASE (Silicon Graphics,
Inc.). Numbering indicates residues where a secondary structure motif
starts or ends. 
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the final arrangement resembling a hand-shake. For this
reason, we will refer to it below as a β-clasp structure.
Each equivalent half of the clasp thus consists of strands
β3a′, β7, β6, β2 and β3b (where the prime indicates a con-
tribution from the other subunit). β3a′, β7 and β3b are par-
allel to each other and antiparallel to β6 and β2.
Chothia and Janin [9] have described how β bends are
often used to close off the diagonal corners of orthogonal β
sheets. In ribokinase, β3 and its twofold related equivalent
strand β3′ comprise one such pair of diagonal corners. The
other corners of the barrel are more open, with the inter-
vening space filled by four phenylalanine and four proline
residues. The interactions in the core region between the
sheets are mostly of hydrophobic nature and involve
valine, isoleucine and leucine residues. A total of 1250 Å2
of surface area is buried per subunit.
At first inspection, the β-clasp region bears striking simi-
larity to two families of ligand-binding and transport pro-
teins. Proteins of both the serum retinol-binding protein
and the fatty acid/cellular retinoid-binding protein fami-
lies are built up from orthogonal β sheets and feature β
strands that are shared between the front and back sheets
[13]. In P2 myelin, for example, the first β bend is accom-
plished with β–αR–β conformations and the second by dis-
torted β conformations. In ribokinase, the conformation is
most similar to β–αR–β, but the central residue has a dis-
torted helical conformation and is one of three Ramachan-
dran outliers we observe in the structure [14]. In the
ligand-binding and transport proteins, there is a simple
(+1)n (up-and-down) topology [15] that is missing in ribok-
inase. The ribokinase barrel also lacks an internal space
capable of holding a small molecule ligand.
The structures most similar to the β clasp of ribokinase are
found among proteins for which both sheets are con-
tributed by a single polypeptide chain. To the best of our
knowledge, ribokinase provides the first example in the
PDB [16] where this kind of packing serves as a dimer
interaction. Peanut lectin forms a dimer with an orthogo-
nal sheet interaction [17], but no strand is shared between
the two sheets and the arrangement is more open than the
one seen in ribokinase.
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Figure 2
Schematic representation of a ribokinase dimer, colour ramped
according to residue number starting with red at the N terminus of one
subunit and finishing with blue at the C′ terminus of the other subunit.
(a) The whole dimer is shown with the red and yellow subunit in the
same orientation as the subunit in Figure 1a. The two sets of
substrates bound to the dimer are shown in a ball-and-stick
representation. (b) The β-clasp structure. The prime notation denotes
strands from the adjacent subunit. The view is an approximately 90°
rotation around the visual x-axis from that in (a). The figures were
prepared using MOLSCRIPT [49] as modified by R Esnouf [50].
The active site
There are two active sites per ribokinase dimer; each
spans much of the α/β fold of a single subunit and is par-
tially capped by the β clasp (Figures 1 and 2). Within the
active site, we see electron density for the D-ribose
residue, the ADP part of AMP–PNP and an inorganic
phosphate molecule (Figure 3).
Rather surprisingly, the ATP analogue does not bind at
the usual position occupied by the nucleotide in proteins
with Rossmann folds; this site instead is taken up by the
ribose. If we superimpose the NAD-binding domain of
elongation factor G [18] on ribokinase, for example, the
ribose moiety of GDP is found almost exactly at the posi-
tion of the ribose substrate of ribokinase. The actual ATP-
binding site of ribokinase is shifted further along the edge
of the β sheet. This places the adenine ring close to the
edge strands of the extension (β11–β13), with the phos-
phate groups of the nucleotide pointing back towards the
ribose-binding site.
Ribose binding
The substrate ribose is almost completely buried, with the
β clasp acting as a lid over its binding site (Figures 2
and 3). There are 11 direct hydrogen bonds between the
five oxygen atoms of the ribose moiety and the protein
(residues Asn14, Asp16, Gly42, Lys43, Asn46, Glu143 and
Asp255). Furthermore, there are two indirect hydrogen
bonds between the ribose oxygen atoms and the main-
chain nitrogens of Gly254, Asp255 and Ala252 via water
molecules. Most of the enzyme residues involved in
hydrogen bonding to the substrate ribose are, in turn, held
in place by other residues, resulting in an intricate
network of hydrogen bonds. All of these interactions occur
on one side of the ribose and almost all of them are associ-
ated with the α/β unit (Figure 3a). The more hydrophobic
face of the sugar ring interacts with aliphatic sidechains (of
four isoleucine residues and one alanine residue), mostly
from the underside of the lid. Although some ribokinases
can use 2-deoxyribose as a substrate [19], in the E. coli
protein this would cause the loss of three hydrogen-
bonding interactions (involving residues 14, 16 and 42),
implying that ribose is its preferred substrate .
Ribose has many different forms in solution. In decreasing
order of frequency, the species are β-pyranose (59%),
α-pyranose (20%), β-furanose (13%), α-furanose (7%) and
open chain (0.1%) [20]. The electron density and hydro-
gen-bonding interactions associated with ribose bound to
ribokinase firmly establish that the sugar is a five-mem-
bered ring of the uncommon α-furanose form (Figure 3).
It seems that the form of ribose selected by a given protein
is determined by the particular situation. For the O5′ atom
of ribose to be available for phosphorylation, the sugar
must be in either the open chain or five-membered ring
form; ribokinase chooses the latter. In the ribose-binding
protein, the only other example in the PDB in which a
protein is in complex with ribose, the sugar is observed in
the β-pyranose form [21]. This is consistent with its role in
collecting sugar from the environment; it is advantageous
to seek the most common form. (Ribose-binding protein
also provides another example in which a nucleotide-
binding fold is associated with binding a non-nucleotide
ligand; although its overall fold is different from that of
ribokinase, ribose is bound in a topologically similar posi-
tion in the two proteins.) Transketolase, which can use
ribose-5-phosphate as a substrate, requires the free alde-
hyde of the open chain form for the sugar to accept a two-
carbon unit from another pentose [22].
Furanose rings can assume a number of different confor-
mations. When bound to ribokinase, the sugar adopts an
unusual puckering in which the ring oxygen, O4′, is in an
endo conformation (Figure 3a). In this conformation, O5′
and the ring oxygen are on the same side of the plane
formed by the other four ring members. This is a rela-
tively high energy form of the sugar, although it has been
observed previously in small molecule structures [23].
When a five-membered ring changes puckering between
the most common conformations, C3′-endo and C2′-endo,
it is believed to go through the O4′-endo puckering in
preference to the O4′-exo. The energy barrier between
the O4′-endo and the C3′- and C2′-endo conformations
has been estimated to be 3.8 kcal/mol [24]. Ribokinase
could either select the rare conformation from the popula-
tion in solution or alternatively bind a more common form,
then convert it to O4′-endo. The sugar conformation as
observed is stabilised by hydrogen-bonding interactions,
particularly that between O4′ and the sidechain amino
group of Lys43.
Binding of the ATP analogue
The nucleotide-binding site is located in a shallow groove
in the α/β-fold domain, next to the substrate ribose but
not covered by the lid. The adenine base is stacked
between the mainchain atoms in the β turn connecting
strands β11 and β12 (residues 225 to 226) and the
sidechain of Val286 (in α9). It is further positioned by the
loop joining the edge strand of β13 to α8. There is evi-
dence for some flexibility in this loop, as these residues
have relatively high temperature factors (average 40 Å2 for
all atoms of the loop). The N1 and N3 atoms of the
adenine make a total of five water-mediated hydrogen
bonds to mainchain atoms of the protein (residues 243,
245 and 279; Figure 3c). In contrast to the substrate ribose,
the sugar of the nucleotide analogue has the more
common C3′-endo puckering. This ribose moiety forms
one hydrogen bond with the protein, from its O2′ atom to
His279 ND1.
The α-phosphate of the nucleotide analogue is positioned
about 6 Å from the N terminus of α6. One of the
186 Structure 1998, Vol 6 No 2
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The active site of ribokinase. (a) The ribose-binding site. The electron
density around the ribose is obtained from a SigmaA-weighted
difference map (mFobs–dFcalc′αcalc [46]) calculated to 1.84 Å resolution
before any substrates were included in the refinement. The black lines
correspond to hydrogen-bond distances ≤ 3.2 Å. (b) Electron density
of the final 2mFobs–dFcalc map calculated to 1.84 Å resolution and
displayed around the bound substrate and water molecules. The
colouring of the ribbon is the same as that in Figure 1a and the
substrates (orange carbon atoms) and the sidechain of Asp255
(yellow carbon atoms) are drawn in ball-and-stick representations. The
view is an approximately 90° rotation around the visual x-axis from the
lower subunit in Figure 1a. (c) Schematic drawing of hydrogen-
bonding interactions (≤ 3.2 Å) of the substrates to protein and water
molecules (W); only polar hydrogen atoms of substrates are shown.
Carbon atoms are numbered for the ribose substrate. Residues from
the adjacent subunit (Gly28 and Thr30) are indicated by the prime
notation. Gly254 is drawn twice to clarify the figure. The figure was
prepared using O [42] and CSC ChemDraw (Cambridge Scientific
Computing, Inc.).
α-phosphate oxygen atoms is within hydrogen-bonding
distance of both the mainchain nitrogen atom of Gly225
and the hydroxyl oxygen atom of Thr223 at the C-termi-
nal end of strand β11. The oxygen that bridges the α- and
β-phosphate groups interacts with a water that is within
hydrogen-bonding distance of several other groups
(Figure 3c). There is no electron density observed for the
γ-phosphate group of AMP–PNP in the electron-density
map, although that of the β-phosphate group is clear
(Figure 3b). The β-phosphate group is involved in one
direct and three water-mediated hydrogen bonds to the
protein. As there are well-ordered water molecules in the
space that should be occupied by the γ-phosphate group,
it seems likely that the AMP–PNP was hydrolysed to form
AMP–PN or ADP. As these two possibilities cannot be
distinguished from each other with the present data, our
model treats the nucleotide analogue as ADP. The hydrol-
ysis of AMP– PNP presumably occurred before binding to
the enzyme, because the substrate, ribose, rather than the
product, ribose-5-phosphate, is observed in the active site.
The distance between the β-phosphorus atom of the
bound dinucleotide and the pertinent oxygen of the sub-
strate ribose is 7.2 Å, which compares well with the range
of distances from 6.7 to 7.2 Å observed in ternary com-
plexes of phosphofructokinase [25].
There are fewer direct hydrogen bonds between the
nucleotide and protein than are observed for the substrate
ribose. As observed in other proteins, recognition of the
nucleotide is more dependent on van der Waals interac-
tions. This type of binding apparently allows somewhat
more mobility and probably explains why the electron
density for nucleotide is slightly weaker and the average
temperature factor higher than those found for ribose.
We do not see evidence for a bound metal ion in our elec-
tron-density maps, although Mg2+ was included in the
crystallisation mixture. The absence of metal may be asso-
ciated with the loss of the γ-phosphate group or with the
high ionic strength of the crystallisation medium.
Reaction mechanism
Ribokinase requires ribose, ATP and magnesium for the
phosphorylation reaction to take place. The structural
arrangement strongly suggests that the γ-phosphate
group of the trinucleotide will be positioned at the N-
terminal end of α8, between the observed positions of
the oxygen that is phosphorylated and the β-phosphate
of the ATP donor. It would then be involved in hydro-
gen bonds to the mainchain nitrogen atoms of residues
252–255 of the helix.
The distance between a γ-phosphorus atom modelled
onto the dinucleotide and the ribose O5´ atom is approxi-
mately 5.6 Å. Comparable atoms in ternary complexes of
phosphofructokinase are separated by 4.3–5.9 Å [25].
These distances are slightly greater than would be consid-
ered optimal for phosphoryl transfer, so it is presumed that
some minor structural rearrangement must take place
during the ribokinase reaction. Given the many specific
interactions between ribose and the protein, and the
paucity of interactions between protein and nucleotide, it
seems more likely that the nucleotide will move. Confor-
mational changes with a similar role have been demon-
strated for phosphofructokinase [25].
Two main mechanisms have been proposed for kinase-
catalysed reactions, both of which seem to be relevant to
ribokinase. In phosphofructokinase [26], an aspartic acid
residue is believed to act as a base to encourage deproto-
nation of the pertinent sugar hydroxyl group and so to acti-
vate it for nucleophilic attack on the γ-phosphate of ATP.
An alternate mechanism has been proposed for NMP
kinases, G proteins and others (summarised in [27]), in
which the transition state is stabilised by an anion hole
created by the combination of mainchain amide nitrogens
and conserved, positively charged, sidechains. We believe
that E. coli ribokinase uses Asp255 as the base to abstract a
proton from the O5′-hydroxyl group of ribose. The nega-
tively charged O5′ atom could then make a direct nucle-
ophilic attack on the γ-phosphate group of ATP in an
in-line mechanism. The resulting transition state would
have a pentacovalent geometry and be stabilised by an
anion hole created by the mainchain nitrogens of residues
252–255 and by its position at the N-terminal end of α8.
The transition state may be further stabilised by the
sidechain of Lys43, which is observed to be involved in
sugar binding but may be able to change conformation
during the reaction. The products, ribose-5-phosphate and
ADP, would then be formed by an SN2 reaction. It is not
clear what role the unusual form of the ribose substrate
might have in the reaction chemistry.
As ribose is buried within the binding site, some conforma-
tional changes are probably required for the ribose to get in
and ribose-5-phosphate to get out. The β-clasp lid may
close and open upon binding and release, respectively.
Such conformational changes have been observed for other
kinases, of which hexokinase is a classical example [28].
The number of interactions between the lid and the
central α/β fold is relatively small, and so the protein may
open more frequently in the absence of ribose. Entry of
ribose into the binding site would be expected to favour
closing of the lid, as a result of the many hydrophobic
interactions between the lid and sugar. It also seems signif-
icant that the γ-phosphate group of ATP will be brought
into proximity with the O5′ atom of the substrate ribose at
the precise edge of the lid (Figure 4), suggesting that
closing may assist in the subsequent binding of nucleotide,
as has been demonstrated for hexokinase [29,30]. The
assembled ternary complex would create a controlled
microenvironment to optimise phosphoryl transfer.
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Figure 4
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Structure
Sequence conservation among ribokinases. (a) Alignment of six
ribokinase sequences, using the program CLUSTAL W [51], from: E.
coli, Escherichia coli (SWISS-PROT accession number P05054); H.
influenzae, Haemophilus influenzae (P44331); B. subtilis, Bacillus
subtilis (P36945); C. elegans, Caenorhabditis elegans (EMBL
accession number Z66511); M. tuberculosis, Mycobacterium
tuberculosis (Z81451); and S. cerevisiae, Saccharomyces cerevisiae
(SWISS-PROT accession number P25332). The numbering above the
alignment corresponds to the E. coli sequence; strands and helices of
that structure are shown in black. Residues that bind ribose or
nucleotide are marked R or A, indicating a hydrogen bond with ribose
or ADP, respectively, r or a, an indirect hydrogen bond via one water
molecule, and H or h, residues that make van der Waals contacts
(distance ≤ 4 Å) with ribose or ADP, respectively. The two sequence
motifs discussed in the text are underlined. The figure was prepared
using the program ALSCRIPT [52]. Residues that are identical in all
sequences are marked in red, those identical in more than four out of
six sequences in yellow and those that are conserved but not identical
in green. Conservation was calculated in ALSCRIPT using a
conservation value of six. (b) Stereo diagram of the ribokinase subunit
coloured according to residue conservation as above. The non-
conserved residues are shown in black and all substrates in cyan.
Residues were labeled to allow the reader to follow the sequence. A
segment from the second subunit that contributes to the binding site is
shown in grey with blue numbering (residues 27′–32′). The view is
similar to that in Figure 3b. The diagram was prepared using O [42].
The role of a dimer in ribokinase function is not clear. As
shown in Figure 3c, only two residues from the opposing
subunit (Thr30′ and Gly28′) form hydrogen bonds in the
active-site region. The strand in which they reside, β3a′
(the green strand in Figure 2), however, is important in
shielding bound ribose from the solvent. As these residues
are highly conserved among ribokinases (Figure 4), it
seems likely that this aspect of dimer formation is impor-
tant for activity. There is no available data concerning pos-
sible cooperativity or allosteric control of this enzyme.
An inorganic phosphate is observed in the active site,
forming interactions with both subunits (Figure 3).
Although its presence in the structure may be related to
the high concentration of ammonium phosphate in the
crystallisation solutions, it forms direct and indirect hydro-
gen bonds with residues that are highly conserved in the
broad ribokinase family. At least one family member,
adenosine kinase, has been reported to be activated by
physiological concentrations of phosphate [31].
The ribokinase family
Ribokinase is a member of a large family of prokaryotic
and eukaryotic carbohydrate kinases [5,6]. This ribokinase
family, also called the PfkB family, phosphorylates the
hydroxymethyl groups of a variety of sugar moieties.
BLAST searches [32] suggest that, in order of sequence
similarity to ribokinases, the other members are ketohex-
okinase, adenosinekinase, fructokinase, 2-dehydro-3-
deoxygluconokinase, 1-phosphofructokinase and the
minor 6-phosphofructokinase (PfkB).
In Figure 4, we have aligned six sequences that we
believe represent ribokinases, based on the E. coli
sequence and structure. C. elegans and M. tuberculosis
sequences are described in their GenBank headers as
proteins of unknown function, but they fit well with our
criteria for a ribokinase. In contrast, the sequence entries
for two other proteins from Methanococcus jannaschii (PIR
locus F64350) and Sulfolobus solfatarious (GenBank
accession number U52110) carry notations that they are
probably ribokinases, but they were left out of this align-
ment. These archaebacterial sequences are similar to
others from the ribokinase family, but lack essential and
otherwise conserved residues that interact with ribose,
and so they probably phosphorylate other sugars. We also
found a total of nine short sequences in the data bases
from the human genome sequencing project, HUGO
(accessed through NCBI’s UniGene), that taken together
represent most of the ribokinase sequence. Although this
sequence is incomplete, it demonstrates the presence of
a human ribokinase with approximately 30% identity to
the E. coli protein.
Residues for which the structure suggests an important
role in ribokinase function are highly conserved
(Figure 4). Of the seven sidechains that make specific
hydrogen bonds with ribose, only Asn14 is replaced by a
different amino acid in some sequences. Similarly, the
residues making direct (Asn187, Thr223 and Gly225) and
indirect interactions with the nucleotide are present in
all ribokinases. The aspartic acid thought to act as a cat-
alytic base (Asp255) and the residues at the N-terminal
end of α8, which are implicated in stabilisation of the
transition state, are also absolutely conserved. The
lengths and character of the segments corresponding to
the strands of the protruding β sheet are similar, imply-
ing that all the ribokinases possess a lid resembling the
one described here and are dimers. The most obvious
stretch of sequence homology in the first pair of lid
strands (β2 and β3) is near residues 27–31 at the begin-
ning of β3a′, where residues of the second subunit help
close off the binding site (Figure 2). There is more con-
servation throughout the second pair of lid strands (β6
and β7), in agreement with their closer interaction with
ribose and the α/β unit. The hydrophobic nature of most
of the lid interactions, however, allows more variation in
these sequences.
After analysis of our structure, we have defined a motif
(residues 41–55 of the E. coli sequence; Figure 4) that
specifically locates ribokinases in sequence searches. The
complete motif corresponds almost exactly to helix α1,
and its sequence is conserved for a variety of structural
and functional reasons. Four residues at the N-terminal
end of the helix are involved in direct (Gly42, Lys43 and
Asn46) or indirect (Gln47) interactions with the ribose
substrate; nearby glycine residues are required for confor-
mational and steric reasons. The C-terminal portion of the
helix is completely buried, and the small hydrophobic
sidechains of the residues between Gly44 and Gly52 make
many interactions with neighbouring elements of the
structure. Gly55 is in a classical helix breaking conforma-
tion that has a strong glycine preference [33], thus
marking the end of α1 as well as of the motif.
Conservation within the broader family is associated with
nucleotide binding and the catalytic machinery, but not
specifically with binding of the sugar substrate. The
equivalent of Asp255 (the catalytic base) is absolutely con-
served in all members of the ribokinase family, as are the
alanine and glycine residues immediately preceding it
(important in forming the anion hole). This suggests that
the basic mechanism of the phosphorylation reaction will
be the same for all family members, although the binding
site must be redesigned to fit the different substrates. The
segments corresponding to the lid of E. coli ribokinase are
not very well conserved, but their similar lengths and a
few key features suggest that all family members will have
a lid, although it may not always be involved in dimerisa-
tion. At least one family member, adenosine kinase, has
been reported to act as a monomer [34]. Various consensus
190 Structure 1998, Vol 6 No 2
sequences have been described for the family as a whole
[5,6,34]. On the basis of our structure, we can propose a
similar, but more meaningful, motif including residues
245–261 of the E. coli protein (Figure 4). This second
motif includes part of the binding site for the adenine
ring, the N-terminal end of helix α8 that forms the anion
hole (residues 252–255) and the catalytic base. Other
residues in the motif are conserved for structural reasons.
The relevant portion of α8 is buried and immediately
adjacent in the structure to the ribokinase-specific motif
described above. Thr250, which is replaced by a serine
residue in some family members, stabilises the closed
position of the ribokinase lid through a hydrogen bond to
the mainchain oxygen of Gly106.
Biological implications
The phosphorylation of sugars is key to their role in
energy production and biosynthesis, and the addition of
the charged group also prevents leakage of neutral
sugars across biological membranes. Many aspects of
phosphorylation reactions, however, remain poorly
understood. The enzyme ribokinase carries out the
essential phosphorylation of ribose in both prokaryotes
and eukaryotes. The structure of ribokinase in ternary
complex with sugar substrate and nucleotide adds
greatly to our understanding of this step. As the first
structure to be determined from a large family, riboki-
nase gives many insights into an entire class of carbohy-
drate kinases. Ribokinase consists of an α/β unit, which
provides most of the substrate specificity, with a pro-
truding β sheet that acts as a lid over part of the active
site. Other striking features include a novel nucleotide-
binding fold, a dimer interface formed by orthogonally
packed β sheets and an unusual conformation of the
sugar substrate.
Ribokinase action seems to follow patterns that have
been established previously for other kinases. Ribose is
trapped under the lid in the present structure, suggest-
ing that opening and closing of the lid may be an impor-
tant aspect in catalysis. The sugar is expected to firstly
bind the open form of the enyzme and then stabilise the
observed closed conformation, in which the relevant
substrate groups and catalytic apparatus are assembled
just under the edge of the lid. ATP binding should be
enhanced in the closed form, largely as a result of
improved interactions with its γ-phosphate group. It
has been suggested that kinases use such ordered
binding of substrates as a means of preventing prema-
ture ATP hydrolysis. Both common modes of kinase
catalysis, that is substrate activation and transition-
state stabilisation, are implicated in phosphoryl trans-
fer between the two substrates in ribokinase. Our
current structure will serve as a good starting point
for further investigations into these chemical and
conformational aspects.
Materials and methods
Purification and crystallisation
E. coli ribokinase was overexpressed and purified as described previ-
ously [12]. To obtain the SeMet form of the protein, a Met– strain, DL41
(F–, λ–, MetA–), was transformed with the pJGK10 plasmid. Cells were
grown in a defined medium [35] omitting methionine, but supple-
mented with 50 mg DL-selenomethionine (SeMet), 1 mg thiamine, 10 ml
of a vitamin supplement (Kao and Michayluk, Sigma Chemical
Company) and 50 mg ampicillin per litre of culture medium. The purifi-
cation was performed as for the wild-type protein [12] but all buffers
were degassed and 2 mM EDTA and 1 mM β-mercapto ethanol were
added. No EDTA was added, however, to the loading buffer for the
dye-binding column. The nearly 100% incorporation of SeMet was con-
firmed by a total amino acid analysis using β-mercapto sulfonic acid
hydrolysis to avoid methionine degradation.
Crystallisation of both wild-type and the SeMet form of the protein was
carried out at either 15°C or 20°C in hanging drops. Crystals were
grown in the presence of 0.5 mM ribose, 10 mM AMP–PNP and
10 mM MgCl2, using 2.1–2.4 M NH4H2PO4 as precipitant and buffered
at pH 8.4 with 0.1 M Tris-HCl as described previously [12]. Due to the
lower solubility of the SeMet protein, the protein concentration in the
drop was reduced from 5.5 mg/ml to 3.5 mg/ml. Most crystals were
grown using pooled peaks from the last chromatography step [12],
although the highest resolution was obtained using the first ribokinase
peak only.
Data collection and structure solution
All data sets were collected from crystals flash-frozen in liquid nitro-
gen following a 2–5 min soak in buffer containing 20% glycerol. Both
native and SeMet data sets were collected at the EMBL Outstation at
DESY, Hamburg, using a MAR Research imaging plate detector. The
native 2.6 Å data set and the SeMet data set were collected on beam
line X11 and the native 1.84 Å data on beam line BW7B. The mercury
acetate data were collected on a Rigaku R-AXIS imaging plate
mounted on a rotating anode X-ray source. All images were integrated
and scaled using the HKL suite of programs [36]. Further processing
was carried out using programs from the CCP4 package [37]. Data
collection statistics are shown in Table 1. The space group was deter-
mined to be either P6122 or the enantiomorph P6522 with one mol-
ecule in the asymmetric unit (Vm = 3.1; [38]). A difference Patterson
map between the 2.6 Å native data and the mercury acetate data set
was calculated to 3.0 Å resolution. One mercury site was found using
the program RSPS [39]. Its position and occupancy were refined and
then phases calculated using the program MLPHARE [40]. Further Hg
sites, and later SeMet sites, were found using difference Fourier
maps. The SeMet positions could also be located using a difference
Patterson maps calculated between the native and the SeMet data
sets. The initial MIR map calculated with phases to 3.0 Å showed
solvent boundaries (FOMcentric = 0.63, FOMacentric = 0.41). Solvent
flattening and histogram matching with DM [41], using a solvent
content of 49%, produced a map that was easily interpretable. The
space group could then be determined to be P6122 by inspection of
the handedness of the helices. The initial model was built in O using
skeletonised density, mainchain and sidechain databases and baton
building methods [42,43]. This model included all residues between 6
and 308.
Refinement and analysis
Initial refinement was carried out in X-PLOR [44] against the 2.6 Å
resolution data, using the slow cool procedure of simulated annealing
[45] starting at 2000 K. A random selection of 10% of the data was
set aside for use in the Rfree calculation [7]. After four cycles of
rebuilding interspersed with further cycles of simulated annealing and
grouped temperature factor refinement, the Rfactor was 27.4%
(7.5–2.6 Å) and the corresponding Rfree was 33.6%. After this point,
the 1.84 Å resolution data set was used in the refinement. The model,
which contained only protein atoms, was then subjected to rigid body
refinement (10.0–3.0 Å) followed by simulated annealing in X-PLOR
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(7.5–1.84 Å). Further refinement was carried out in REFMAC [46],
using all reflections between 28 and 1.84 Å and a bulk solvent
correction calculated in X-PLOR. Final rounds included anisotropic
scaling of the data. As the γ-phosphate portion of the AMP–PNP
could not be located in the electron-density maps, an ADP molecule
was used in the refinement. The final Rfactor is 22.0% (28–1.84 Å)
and the Rfree is 25.8%; a cycle including all data gave an Rfactor of
22.1%. This model contains all residues from 4 to 309, ribose, ADP,
two inorganic phosphates and 181 water molecules. One phosphate
molecule is situated on a crystallographic symmetry axis and has
been assigned an occupancy of 0.5. Only 1.1% of residues are out-
liers in a stringent boundary Ramachandran plot [47]. The rms differ-
ences from ideal bond lengths and angle distances [48] are 0.013 Å
and 0.028 Å, respectively. The average temperature factor of the
protein is 28 Å2, whereas those for the ribose, ADP, inorganic
phosphates and water molecules are 22, 42, 37 and 40 Å2, respec-
tively. The rms difference in temperature factors between bonded
atoms is 2.5 Å2. All solvent accessibility calculations were carried out
in X-PLOR.
Molecular images
VRML molecular images of ribokinase and of the complete electron
density are available on http://alpha2.bmc.uu.se/~jill/rk. 
Accession numbers
The coordinates for the final model and structure factor amplitudes
have been deposited in the PDB with entry code 1rkd.
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